Key facts
- Notable investors include Boost VC.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Treat (Services (B2C Non-Financial))
- ·The full record, as it builds
Funding rounds
No funding rounds for Treat (Services (B2C Non-Financial)) are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Treat (Services (B2C Non-Financial))
Operator of a veterinary research firm intended to run clinical trials for pets. The company offers pet health research and regulatory support by conducting decentralized, ethical, real-world clinical trials using home-based pets instead of livestock, enabling clients to get insights into naturally occurring diseases and conditions and get access to recruitment capabilities to tailor their studies for everything from breed, age, diet, and diseases.
- Sector
- Consumer Products and Services (B2C)
- HQ
- Singapore, Singapore
- Founded
- 2021
- Employees
- 2
- Website
- treatx.bio/
- Ownership
- Privately Held (backing)
Treat (Services (B2C Non-Financial)) doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Treat (Services (B2C Non-Financial)) shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Treat (Services (B2C Non-Financial)) in its N-PORT filings yet. We sweep new filings monthly.